CAR-T shows 'impressive efficacy' for patients with advanced multiple myeloma - Healio

6/5/2022 12:00:00 AM2 years 10 months ago

CHICAGO — A novel chimeric antigen receptor T-cell therapy has elicited objective responses among the first eight patients who received the treatment, according to results from the phase 1 POLARIS trial presented at ASCO Annual Meeting. Use of OriCAR-01…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio CHICAGO — A novel chimeric antigen recep… [+3765 chars]

full article...

CAR-T shows 'impressive efficacy' for patients with advanced multiple myeloma - Healio

CHICAGO &mdash; A novel chimeric antigen receptor T-cell therapy has elicited objective responses among the first eight patients who received the treatment, according to results from the phase 1 POLARIS trial presented at ASCO Annual Meeting. Use of OriCAR-01…

CHICAGO — A novel chimeric antigen receptor T-cell therapy has elicited objective responses among the first eight patients who received the treatment, according to results from the phase 1 POLARIS trial presented at ASCO Annual Meeting. Use of OriCAR-01…